tiprankstipranks
Trending News
More News >
Centrex Limited (AU:CXM)
ASX:CXM
Australian Market

Centrex Limited (CXM) AI Stock Analysis

Compare
5 Followers

Top Page

AU

Centrex Limited

(Sydney:CXM)

Rating:45Neutral
Price Target:
AU$0.00
▼(-100.00%Downside)
Centrex Limited's overall score reflects its mixed financial performance, with notable revenue growth but persistent profitability and liquidity challenges. Technical indicators suggest bearish momentum with potential oversold conditions, while the negative valuation metrics indicate profitability issues. The absence of earnings call insights and corporate events limits the assessment to existing financial and market data.

Centrex Limited (CXM) vs. iShares MSCI Australia ETF (EWA)

Centrex Limited Business Overview & Revenue Model

Company DescriptionCentrex Limited (CXM) is a technology solutions company specializing in software development and IT consulting services. The company operates primarily within the information technology and digital transformation sectors, offering a wide range of products and services designed to enhance business operations through innovative technology solutions. Centrex Limited's core offerings include custom software development, cloud computing solutions, IT infrastructure management, and cybersecurity services, catering to a diverse clientele across various industries.
How the Company Makes MoneyCentrex Limited makes money through a combination of project-based and subscription-based revenue models. Its key revenue streams include fees from custom software development projects, which are typically contracted on a fixed-price or time-and-materials basis. Additionally, the company generates recurring revenue from its cloud computing solutions and managed IT services, which are offered on a subscription basis. Centrex also earns income from consulting services and cybersecurity solutions, providing strategic guidance and security assessments to businesses. Strategic partnerships with leading technology providers further enhance its service offerings, allowing Centrex to leverage cutting-edge technologies and expand its market reach.

Centrex Limited Financial Statement Overview

Summary
Centrex Limited's financial health presents a mixed picture. While revenue growth is a positive indicator, persistent losses and negative cash flows suggest operational inefficiencies and liquidity challenges. The balance sheet remains stable with a solid asset base, but increasing debt levels might affect financial flexibility. The company needs to focus on improving profitability and cash flow generation to enhance its financial standing.
Income Statement
42
Neutral
Centrex Limited's revenue growth has been notable, increasing from 2019 to 2024, but the company struggles with consistently negative gross and net profit margins. The gross profit margin is negative due to the high cost of goods sold, and the net profit margin is also negative, reflecting ongoing operational challenges. Despite this, revenue has shown significant growth, particularly from 2022 to 2024, indicating potential future revenue stability.
Balance Sheet
55
Neutral
The balance sheet shows a moderate debt-to-equity ratio, which has increased over the years due to rising debt levels. However, the equity ratio remains relatively strong, indicating a solid asset base. Return on equity is negative, reflecting the company's continued unprofitability. Overall, the balance sheet exhibits stability in assets, but rising debt levels could pose future risks.
Cash Flow
38
Negative
Centrex Limited's cash flow statement highlights negative free cash flow and operating cash flow over multiple years, which raises concerns about liquidity and operational efficiency. The company has been investing heavily, as seen in the capital expenditures, but without corresponding positive cash flow from operations. Financing activities have provided some relief, but continuous reliance on external financing could be unsustainable.
BreakdownJun 2024Jun 2023Jun 2022Jun 2021Jun 2020
Income Statement
Total Revenue30.65M25.97M214.00K0.000.00
Gross Profit-8.54M381.00K-1.25M-12.00K-14.00K
EBITDA-15.39M-8.54M-21.29M-2.59M-19.80M
Net Income-19.32M-9.55M-21.66M-2.63M-19.82M
Balance Sheet
Total Assets54.88M43.13M36.37M14.69M13.01M
Cash, Cash Equivalents and Short-Term Investments2.55M6.74M12.87M2.19M1.81M
Total Debt8.16M6.53M151.00K0.000.00
Total Liabilities34.09M18.31M4.68M3.41M312.00K
Stockholders Equity20.79M24.82M31.70M11.29M12.70M
Cash Flow
Free Cash Flow-15.75M-9.41M-9.22M-1.63M-3.50M
Operating Cash Flow-9.06M-6.96M-1.57M-915.00K-2.20M
Investing Cash Flow-6.73M-2.48M-6.79M-385.00K1.37M
Financing Cash Flow11.58M3.33M19.90M2.19M0.00

Centrex Limited Technical Analysis

Technical Analysis Sentiment
Negative
Last Price0.01
Price Trends
50DMA
0.01
Negative
100DMA
<0.01
Positive
200DMA
0.02
Negative
Market Momentum
MACD
>-0.01
Negative
RSI
1.10
Positive
STOCH
<0.01
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:CXM, the sentiment is Negative. The current price of 0.01 is below the 20-day moving average (MA) of 0.01, below the 50-day MA of 0.01, and below the 200-day MA of 0.02, indicating a bearish trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 1.10 is Positive, neither overbought nor oversold. The STOCH value of <0.01 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AU:CXM.

Centrex Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (58)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
AUBHP
75
Outperform
$183.25B10.6026.20%4.38%-2.47%57.01%
AUILU
71
Outperform
$1.60B6.4510.39%2.29%-9.35%-32.77%
AUIGO
62
Neutral
$3.12B1,418.92-36.53%12.97%-28.50%-532.61%
AUS32
58
Neutral
£13.22B58.57-3.53%3.72%-19.74%
AUMIN
58
Neutral
$3.94B50.78-33.95%4.54%2.22%-411.10%
58
Neutral
AU$879.13M4.42-2.39%4.85%22.34%-112.43%
AUCXM
45
Neutral
AU$14.75M-84.72%18.04%-69.23%
* Utilities Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
AU:CXM
Centrex Limited
0.01
-0.03
-75.00%
AU:ILU
Iluka Resources Limited
3.84
-2.72
-41.50%
AU:BHP
BHP Group Ltd
37.53
-3.71
-9.00%
AU:S32
South32
2.94
-0.66
-18.33%
AU:MIN
Mineral Resources Limited
21.22
-33.72
-61.38%
AU:IGO
IGO
4.12
-1.42
-25.60%

Centrex Limited Corporate Events

Centrex Limited Creditors Approve Deed of Company Arrangement with PRL Global
Jun 17, 2025

Centrex Limited, currently under voluntary administration, and its subsidiary Agriflex Pty Ltd, have resolved to enter into a Deed of Company Arrangement (DOCA) with PRL Global Limited. This decision was made during the reconvened second meeting of creditors. The execution of the DOCA will involve the transfer of all Centrex shares to PRL, pending a court order, and is expected to impact shareholders, who are advised to seek legal and tax advice.

PRL Global Secures Creditor Approval for Centrex Ltd DOCA
Jun 17, 2025

PRL Global Limited has successfully completed the second creditors meeting for Centrex Ltd and its subsidiary Agriflex Pty Ltd, owners of the Ardmore phosphate mine in Queensland. Creditors voted in favor of PRG’s Deed of Company Administration (DOCA) proposal, which is contingent upon reaching binding agreements with key partners, including Aurizon, the rail haulage services provider. The economic viability of the Ardmore Phosphate Mine hinges on these agreements, with a deadline set for June 27, 2025, to finalize terms with Aurizon.

Centrex Limited’s Future Hinges on Creditor Meeting Decision
Jun 10, 2025

Centrex Limited, currently under voluntary administration, has scheduled a reconvened second meeting of creditors to decide on the future of the company. The administrators recommend accepting a deed of company arrangement proposed by PRL Global Limited, which involves compromising unsecured creditor debts and transferring Centrex’s shares to PRL, with no return to shareholders. The outcome could significantly impact the company’s operations and stakeholders, depending on whether creditors accept the proposal, return control to directors, or opt for liquidation.

Centrex Limited Defers Financial Reporting Amid Administration
Apr 28, 2025

Centrex Limited, currently under voluntary administration, has announced a deferral of its financial reporting obligations. The company, along with its subsidiary Agriflex Pty Ltd, is utilizing relief provisions under ASIC regulations to delay financial reporting for up to 24 months. This deferral is part of the administration process managed by FTI Consulting, which aims to stabilize the company’s operations. During this period, Centrex’s securities remain suspended from trading, ensuring no uninformed trading occurs. The company has set up communication channels for shareholders to address any queries regarding the administration process.

Centrex Limited Selects PRL Global Ltd for Exclusive Due Diligence
Apr 16, 2025

Centrex Limited, currently under administration, has announced that PRL Global Ltd has been selected as the preferred bidder for the potential sale or recapitalization of the company. The decision follows discussions with shortlisted bidders, and PRL Global Ltd will now enter a 45-day exclusive due diligence period. This development could significantly impact Centrex Limited’s future operations and market positioning, with further updates expected after the due diligence period concludes.

Centrex Limited Adjourns Creditors Meeting Amid Sale Negotiations
Apr 1, 2025

Centrex Limited, currently under administration, has announced the convening of a second meeting of creditors, initially scheduled for April 8, 2025. The administrators are in advanced negotiations for a potential sale or recapitalization of the company, which may involve a Deed of Company Arrangement. To allow more time for these negotiations, the meeting will be adjourned for up to 45 business days, with a supplementary report to be issued detailing potential outcomes and recommendations for creditors.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jun 26, 2025